4-chloro-o-phenylenediamine: A 26-week oral (in feed) mutagenicity study in Big Blue(TM) mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 414, Issue 1-3, 1998, Pages 149-156

  Suter, Willi ^a   Staedtler, Frank ^a   Poetter Locher, Franziska ^a   Swingler, Tracey ^a   Wilson, Laura ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

4 Chloro o phenylenediamine; Big Blue(TM); Liver carcinogen; Short term treatment; Subchronic treatment; Transgenic mouse

Indexed keywords

PHENYLENEDIAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CHEMICAL CARCINOGENESIS; LIVER CANCER; LIVER CARCINOGENESIS; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMAL FEED; ANIMALS; BACTERIOPHAGE LAMBDA; BODY WEIGHT; FEMALE; LAC OPERON; LIVER; MALE; MICE; MUTAGENS; ORGAN SIZE; PHENYLENEDIAMINES; TRANSFECTION;

ANIMALIA; ESCHERICHIA COLI; MUS MUSCULUS;

EID: 0032507655     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(98)00050-3     Document Type: Article

References (28)

1. Ashby J., Liegibel U. Transgenic mouse mutation assays: potential for confusion of genotoxic and non-genotoxic carcinogenesis: a proposed solution. Environ. Mol. Mutagen. 20:1992;145-147.
2. Ashby J., Liegibel U. Dosing regimens for transgenic animal mutation assays. Environ. Mol. Mutagen. 21:1993;120-121.
3. Mirsalis J. Dosing regimens for transgenic animal mutation assays. Environ. Mol. Mutagen. 21:1993;118-119.
4. Ashby J., Tinwell H. Dosing regimens for transgenic animal mutation assays: the danger of facing in two directions at the same time. Environ. Mol. Mutagen. 25:1995;266-268.
5. Suter W., Ahiabor R., Blanco B., Locher F., Mantovani F., Robinson M., Sreenan G., Staedtler F., Swingler T., Vignutelli A., Perentes E. Evaluation of the in vivo genotoxic potential of three carcinogenic aromatic amines using the Big Blue™ transgenic mouse mutation assay. Environ. Mol. Mutagen. 28:1996;354-362.
6. US Department of Health, Education and Welfare, Bioassay of 4-chloro-o-phenylenediamine for possible carcinogenicity, NCI Carcinogenesis Technical Report Series 63, US Department of Health, Education and Welfare, Public Health Service, National Institutes of Health, Bethesda, MD, 1978.
7. Shephard S.E., Lutz W.K., Schlatter C. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo. Mutat. Res. 306:1994;119-128.
8. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Putman D.L., Sorge J.A., Short J.M. Analysis of spontaneous and induced mutations in transgenic mice using a λ ZAP/lac I shuttle vector. Environ. Mol. Mutagen. 18:1991;316-321.
9. Stratagene, Big Blue™ Transgenic Mouse Mutagenesis Assay Manual, Stratagene, La Jolla, CA, 1992.
10. Dycaico M.J., Provost G.S., Kretz P.L., Ransom S.L., Moores J.C., Short J.M. The Use of shuttle vectors for mutation analysis in transgenic mice and rats. Mutat. Res. 307:1994;461-478.
11. Kohler S.W., Provost G.S., Kretz P.L., Fieck A., Sorge J.A., Short J.M. The use of transgenic mice for short term, in vivo mutagenicity testing. GATA. 7:1990;212-218.
12. Tinwell H., Liegibel U., Krebs O., Schmezer P., Favor J., Ashby J. Comparison of lacI and lacZ transgenic mutation assays: an EU-sponsored interlaboratory study. Mutat. Res. 335:1995;185-190.
13. Crespo-Perez J., Locher F., Swingler T., Wilson L., Steiner S., Suter W., Staedtler F. Dose dependent change in the mutation spectrum of the lacI transgene isolated from Big Blue™ mice subchronically treated with 4-chloro-o-phenylenediamine. Mutat. Res. 379:1997;S148. (Supplement 1).
14. Ashby J., Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutat. Res. 257:1991;229-306.
15. Dunkel V.C., Zeiger E., Brusick D., McCoy E., McGregor D., Mortelmans K., Rosenkranz H.S., Simmon V.F. Reproducibility of microbial mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella typhimurium and Escherichia coli. Environ. Mutagen. 7:1985;1-248. (Supplement 5).
16. Soler-Niedziela L., Shi X., Nath J., Ong T. Studies on three structurally related phenylenediamine with the mouse micronucleus assay system. Mutat. Res. 259:1991;43-48.
17. Morita T., Asano N., Awogi T., Sasaki Y.F., Sato S.-I., Shimada H., Sutou S., Suzuki T., Wakata A., Sofuni S., Hayashi M. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Group 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS:MMS. Mutat. Res. 389:1997;3-122.
18. Heddle J.A., Shaver-Walker P., Tao K.S., Zhang X.B. Treatment protocols for transgenic mutation assays in vivo. Mutagenesis. 10:1995;467-470.
19. Brooks T.M., Szegedi M., Dean S.W. The detection of gene mutation in transgenic mice (Muta™Mouse) following a single oral dose of 2-acetylaminofluorene. Mutagenesis. 10:1995;149-150.
20. Winegar R.A., Lutze L.H., Hammer J.D., O'Loughlin K.G., Mirsalis J.C. Radiation-induced point mutations, deletions and micronuclei in lacI transgenic mice. Mutat. Res. 307:1994;479-487.
21. Brooks T.M., Dean S.W. Detection of skin mutations in skin, stomach and liver of Muta™Mouse following oral or topical treatment with N-methyl-N′-nitro-N-nitrosoguanidine or 1-chloromethylpyrene: some preliminary observations. Mutagenesis. 11:1996;529-532.
22. Tao K.S., Urlando C., Heddle J.A. Comparison of somatic mutation in transgenic versus host locus. Proc. Natl. Acad. Sci. U.S.A. 90:1993;10681-10685.
23. Okada N., Honda A., Kawabata M., Yajima N. Sodium phenobarbital-enhanced mutation frequency in the liver dna of lacZ transgenic mice treated with diethylnitrosamine. Mutagenesis. 12:1997;179-184.
24. Shephard S.E., Sengstag C., Lutz W.K., Schlatter C. Mutations in liver DNA of lacI transgenic mice (Big Blue™) following subchronic exposure to 2-acetylaminofluorene. Mutat. Res. 302:1993;91-96.
25. Hayward J.J., Shane B.S., Tindall K.R., Cunningham M.L. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene. Carcinogenesis. 16:1995;2429-2433.
26. Gorelick N.J. Overview of mutation assays in transgenic mice for routine testing. Environ. Mol. Mutagen. 25:1995;218-230.
27. J.G. De Boer, H.L. Erfle, D. Walsh, J. Holcroft, B.W. Glickman, The use of lacI transgenic mice in genetic toxicology, in: G.P. Pfeifer (Ed.), Technologies for Detection of DNA Damage and Mutations, Plenum, New York, 1996, pp. 411-429.
28. Sofuni T., Suzuki T., Hayashi M. Initial consideration for use of transgenic mutation assays in a regulatory submission. Environ. Mol. Mutagen. 28:1996;443-446.